• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病与注意缺陷多动障碍的相关性:系统评价、荟萃分析和基于人群的同胞研究。

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study.

机构信息

School of Medical Sciences, Örebro University, Faculty of Medicine and Health, Örebro, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

School of Medical Sciences, Örebro University, Faculty of Medicine and Health, Örebro, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

出版信息

Neurosci Biobehav Rev. 2023 Apr;147:105076. doi: 10.1016/j.neubiorev.2023.105076. Epub 2023 Feb 6.

DOI:10.1016/j.neubiorev.2023.105076
PMID:
36754221
Abstract

We conducted a systematic review and a meta-analysis to quantitatively summarize evidence on the association between attention-deficit/hyperactivity disorder (ADHD) and type 2 diabetes (T2D). Moreover, a register-based sibling study was conducted to simultaneously control for confounding factors. A systematic search identified four eligible observational studies (N = 5738,287). The meta-analysis showed that individuals with ADHD have a more than doubled risk of T2D when considering adjusted estimates (OR=2.29 [1.48-3.55], d=0.46). Results from the register-based Swedish data showed a significant association between ADHD and T2D (HR=2.35 [2.14-2.58]), with substance use disorder, depression, and anxiety being the main drivers of the association, and cardiovascular and familiar risk playing a smaller role. While results from the meta-analysis provide evidence for an increased risk of T2D in individuals with ADHD, the register-based analyses show that the association between ADHD and T2D is largely explained by psychiatric comorbidities. Pending further evidence of causal association, our findings suggest that early identification and treatment of ADHD comorbidities might greatly reduce the risk of developing T2D in individuals with ADHD.

摘要

我们进行了系统回顾和荟萃分析,以定量总结注意力缺陷多动障碍(ADHD)与 2 型糖尿病(T2D)之间关联的证据。此外,还进行了基于登记的同胞研究,以同时控制混杂因素。系统搜索确定了四项符合条件的观察性研究(N=5738287)。荟萃分析表明,考虑调整后的估计值,ADHD 个体患 T2D 的风险增加了一倍多(OR=2.29 [1.48-3.55],d=0.46)。来自基于登记的瑞典数据的结果表明,ADHD 与 T2D 之间存在显著关联(HR=2.35 [2.14-2.58]),物质使用障碍、抑郁和焦虑是关联的主要驱动因素,心血管和家族风险的作用较小。虽然荟萃分析的结果提供了 ADHD 个体患 T2D 风险增加的证据,但基于登记的分析表明,ADHD 与 T2D 之间的关联在很大程度上是由精神共病引起的。在进一步证明因果关系的证据之前,我们的研究结果表明,早期识别和治疗 ADHD 共病可能会大大降低 ADHD 个体患 T2D 的风险。

相似文献

1
The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study.2 型糖尿病与注意缺陷多动障碍的相关性:系统评价、荟萃分析和基于人群的同胞研究。
Neurosci Biobehav Rev. 2023 Apr;147:105076. doi: 10.1016/j.neubiorev.2023.105076. Epub 2023 Feb 6.
2
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
3
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
4
Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis.注意缺陷多动障碍儿童的过敏性疾病:一项系统评价和荟萃分析。
BMC Psychiatry. 2017 Mar 31;17(1):120. doi: 10.1186/s12888-017-1281-7.
5
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
6
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
7
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008559. doi: 10.1002/14651858.CD008559.pub2.
8
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
9
Attention-deficit/hyperactivity disorder in children with a history of febrile seizures: a systematic review and meta-analysis.有高热惊厥病史儿童的注意力缺陷/多动障碍:一项系统评价和荟萃分析。
Eur J Pediatr. 2025 Jun 25;184(7):442. doi: 10.1007/s00431-025-06285-4.
10
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.

引用本文的文献

1
Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies.成人注意力缺陷多动障碍(ADHD):循证依据、不确定性与争议
World Psychiatry. 2025 Oct;24(3):347-371. doi: 10.1002/wps.21374.
2
Familial co-aggregation and shared heritability between clinically diagnosed neurodevelopmental problems and cardiometabolic conditions: a nationwide register study across three generations.临床诊断的神经发育问题与心脏代谢疾病之间的家族性共同聚集及共享遗传力:一项三代人的全国性登记研究
Res Sq. 2025 Aug 12:rs.3.rs-6048644. doi: 10.21203/rs.3.rs-6048644/v1.
3
Attention-deficit/hyperactive disorder pre-adulthood and later adverse health outcomes: The 1987 Finnish birth cohort study.
注意力缺陷/多动障碍成年前期与后期不良健康结局:1987年芬兰出生队列研究
Res Sq. 2025 Jul 15:rs.3.rs-6967034. doi: 10.21203/rs.3.rs-6967034/v1.
4
Attention-deficit/hyperactive disorder pre-adulthood and later adverse health outcomes: The 1987 Finnish birth cohort study.注意缺陷/多动障碍成年前期与后期不良健康结局:1987年芬兰出生队列研究
medRxiv. 2025 Jun 24:2025.06.24.25330197. doi: 10.1101/2025.06.24.25330197.
5
General disease factor: evidence of a unifying dimension across mental and physical illness in children and adolescents.一般疾病因素:儿童和青少年精神疾病与身体疾病统一维度的证据。
BMJ Ment Health. 2025 Jun 3;28(1):e301592. doi: 10.1136/bmjment-2025-301592.
6
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025.5. 促进积极的健康行为和福祉以改善健康结局:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S86-S127. doi: 10.2337/dc25-S005.
7
Mediating pathways between attention deficit hyperactivity disorder and type 2 diabetes mellitus: evidence from a two-step and multivariable Mendelian randomization study.中介通路在注意缺陷多动障碍和 2 型糖尿病之间:来自两步法和多变量孟德尔随机化研究的证据。
Epidemiol Psychiatr Sci. 2024 Oct 28;33:e54. doi: 10.1017/S2045796024000593.
8
Changes in parental attitudes toward attention-deficit/hyperactivity disorder impairment over time.父母对注意力缺陷多动障碍损害的态度随时间的变化。
JCPP Adv. 2024 Apr 30;4(3):e12238. doi: 10.1002/jcv2.12238. eCollection 2024 Sep.
9
Cumulative ADHD medication use and risk of type 2 diabetes in adults: a Swedish Register study.累积使用 ADHD 药物与成年人 2 型糖尿病风险:一项瑞典登记研究。
BMJ Ment Health. 2024 Sep 25;27(1):e301195. doi: 10.1136/bmjment-2024-301195.
10
The impacts associated with having ADHD: an umbrella review.与注意力缺陷多动障碍相关的影响:一项综合性综述。
Front Psychiatry. 2024 May 21;15:1343314. doi: 10.3389/fpsyt.2024.1343314. eCollection 2024.